Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk
Authors:
Open Access
- 1 May 2022
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 226 (5) , 683-699
Abstract
No abstract availableKeywords
Funding Information
- University of Florida
- Johns Hopkins University
- College of Medicine, University of Florida
- National Institutes of Health (PO1 HD065647-01A1, R01HD100341)
- Stanford University
This publication has 86 references indexed in Scilit:
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysisHuman Reproduction Update, 2012
- The “Great Obstetrical Syndromes” are associated with disorders of deep placentationAmerican Journal of Obstetrics and Gynecology, 2011
- Cardiovascular effects of relaxin: from basic science to clinical therapyNature Reviews Cardiology, 2009
- Altered Global Gene Expression in First Trimester Placentas of Women Destined to Develop PreeclampsiaPlacenta, 2009
- Relaxin, a pleiotropic vasodilator for the treatment of heart failureHeart Failure Reviews, 2008
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Summary of the NHLBI Working Group on Research on Hypertension During PregnancyHypertension, 2003
- WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1989